Copertina

Network Pharmacology and Transcriptomic Analysis Reveal the Mechanism by Which Ginsenoside CK Remodels the Tumor Immune Microenvironment to Inhibit Liver Cancer Progression

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Fangzhi Ye, Yong Wang, Qiaohui Du, Bin Sun, Ming Zhang, Jinglong Guo
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity
di: Ruoshuang Liu, et al.
Pubblicazione: (2025)

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
di: Tingting Zhang, et al.
Pubblicazione: (2026)

Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments
di: Wu Tao, et al.
Pubblicazione: (2024)

Potential Mechanism of Qiju Dihuang Pill in Treating Primary Sjogren's Syndrome Revealed by Network Pharmacology and Experimental Verification
di: Huiying Wang, et al.
Pubblicazione: (2025)

Promotion Effect of Catalpol on Angiogenesis and Potential Mechanisms: A Research Based on Network Pharmacology
di: Jin‐rong Ni, et al.
Pubblicazione: (2024)

Investigating the Role of Quercetin, an Active Ingredient in Bazhen Decoction, in Targeting CXCL8 to Inhibit Macrophage M2 Polarization and Reshape the Immunological Microenvironment of Colorectal Cancer
di: Wenwu Wang, et al.
Pubblicazione: (2025)

Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression
di: Chenqiang Pan, et al.
Pubblicazione: (2026)

The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation
di: Xiao Cheng, et al.
Pubblicazione: (2025)

Correction to “Nanoemulsion Based Lipid Nanoparticles for Effective Demethylcantharidin Delivery to Cure Liver Cancer”
Pubblicazione: (2024)

Skullcapflavone II Suppresses Colorectal Cancer by Inhibiting the HIF ‐1α‐Glycolysis Pathway
di: Shiwei Yang, et al.
Pubblicazione: (2025)

Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
di: Mei Liu, et al.
Pubblicazione: (2024)

Icaritin Inhibits Malignant Progression and Enhances Ferroptosis and Bortezomib Sensitivity by Suppressing HSP90AA1 Expression in Multiple Myeloma
di: Lin Shi, et al.
Pubblicazione: (2026)

Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
di: Jian Guo, et al.
Pubblicazione: (2024)

Investigation of the Inhibitory Effects and Underlying Mechanisms of Vitexin Derivatives Targeting CDK1 in HCT Colorectal Cancer Cells
di: Ying Zhao, et al.
Pubblicazione: (2026)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
di: Shreetama Bandyopadhayaya, et al.
Pubblicazione: (2025)

Network Pharmacology‐Based Analysis and In Vitro Experiments Validation Reveal Tormentic Acid Induces Apoptosis via PI3K / AKT / HSP90 Pathway in HepG2 Cells
di: Jingyang Lu, et al.
Pubblicazione: (2026)

Plumbagin Triggers STING Pathway Activation to Suppress Non‐Small Cell Lung Cancer Progression
di: Li‐Ping Kang, et al.
Pubblicazione: (2025)

Baicalein Inhibits Tumor Property of Hepatocellular Carcinoma Cells Through the Inactivation of the E2F Transcription Factor 1/Mediator Complex Subunit 7 Axis
di: Pinghui Song, et al.
Pubblicazione: (2025)

Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS ‐Mediated Signaling Pathways in MDA ‐ MB ‐231 Breast Cancer Cells
di: Wen‐Shuang Hou, et al.
Pubblicazione: (2025)

Curculigoside Induces Ferroptosis in Non‐Small Cell Lung Cancer Cells Through a Mechanism Involving Wilms' Tumor 1‐Associating Protein‐Mediated m6A Modification of GTP Cyclohydrolase 1
di: Lizheng Lv, et al.
Pubblicazione: (2026)

Pachymic Acid Suppresses Endometrial Cancer Cell Migration by Inhibiting the NR3C1 / TGF ‐β/Smad Signaling Pathway
di: Yaqiong Wang, et al.
Pubblicazione: (2025)

Tyramine Derivatives as Versatile Pharmacophores With Potent Biological Properties: Sex Hormone–Binding Globulin Inhibition, Colon Cancer Antimigration, and Antimicrobial Activity
di: Jovana S. Marjanović, et al.
Pubblicazione: (2024)

Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition
di: Yuan‐Liang Gao, et al.
Pubblicazione: (2024)

Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance
di: Neha Sharma, et al.
Pubblicazione: (2024)

Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity
di: Hsu‐Feng Liu, et al.
Pubblicazione: (2024)

Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile
di: Ayse Mine Yilmaz, et al.
Pubblicazione: (2025)

Emerging Roles of Osmium Complexes in Cancer Therapy, Their Mechanism of Action, Challenges and Future Perspectives
di: Eman M. Atiyah, et al.
Pubblicazione: (2026)

Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
di: Mohamed El Oirdi
Pubblicazione: (2024)

Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
di: Ze‐Bo Jiang, et al.
Pubblicazione: (2025)

Artesunate Suppresses the Migration and Invasion of Thyroid Cancer Cells via Upregulating PTEN to Block M2 Polarization of Tumor‐Associated Macrophages
di: Zhiwei Xu, et al.
Pubblicazione: (2025)

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
di: S. K. Batin Rahaman, et al.
Pubblicazione: (2025)

Correction to Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
Pubblicazione: (2024)

Network Pharmacology Integrated Experimental Validation Uncover Quercetin as the Key Ingredient of Hedyotis diffusa Anti‐BRCA
di: Queting Chen, et al.
Pubblicazione: (2025)

The Therapeutic Effect and Mechanism of Vismodegib on COPD : Focusing on NETs and Macrophage Polarization
di: Ming Wu, et al.
Pubblicazione: (2026)

Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization
di: Xiangying Li, et al.
Pubblicazione: (2026)

Attempts to Achieve Targeted Covalent Inhibition of Hsp90 β
di: Terin D'Amico, et al.
Pubblicazione: (2026)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
di: Yihao Liu, et al.
Pubblicazione: (2026)

Platinum‐Based Chemotherapeutics in the Modern Era: From Classical DNA ‐Targeting Mechanisms to Next‐Generation Innovations in Cancer Therapy
di: Mohammad Bagher Shahsavani, et al.
Pubblicazione: (2025)

Antioxidant and Amylase, Glucosidase, and Tyrosinase Enzymes Inhibitory Potential of Genistein and 11‐α‐Hydroxyerysotrine Supported by In Silico and Network Pharmacology Approaches
di: Nouran M. Fahmy, et al.
Pubblicazione: (2025)

Integrative Multi‐Omics Analysis Identifies FTO as a Genetic and Epigenetic Link Between Metabolic Susceptibility and Staphylococcus aureus ‐Induced Airway Remodeling in Chronic Rhinosinusitis
di: Xinjie Qiao, et al.
Pubblicazione: (2026)